img

Global Tachykinin Receptor 1 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tachykinin Receptor 1 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Tachykinin Receptor 1 Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tachykinin Receptor 1 Antibody market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Flow Cytometry and Immunocytochemistry are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tachykinin Receptor 1 Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Tachykinin Receptor 1 Antibody key companies include LSBio, Advanced Targeting Solutions, United States Biological, Everest Biotech, NSJ Bioreagents, ProSci, Cusabio, FineTest and GeneTex, etc. LSBio, Advanced Targeting Solutions, United States Biological are top 3 players and held % share in total in 2022.
Tachykinin Receptor 1 Antibody can be divided into Polyclonal and Monoclonal, etc. Polyclonal is the mainstream product in the market, accounting for % share globally in 2022.
Tachykinin Receptor 1 Antibody is widely used in various fields, such as Flow Cytometry, Immunocytochemistry, Immunofluorescence and Western Blot, etc. Flow Cytometry provides greatest supports to the Tachykinin Receptor 1 Antibody industry development. In 2022, global % share of Tachykinin Receptor 1 Antibody went into Flow Cytometry filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tachykinin Receptor 1 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


LSBio
Advanced Targeting Solutions
United States Biological
Everest Biotech
NSJ Bioreagents
ProSci
Cusabio
FineTest
GeneTex
Santa Cruz Biotechnology
Merck
Atlas Antibodies
Proteintech
Boster Biological Technology
Segment by Type
Polyclonal
Monoclonal

Segment by Application


Flow Cytometry
Immunocytochemistry
Immunofluorescence
Western Blot
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tachykinin Receptor 1 Antibody market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Tachykinin Receptor 1 Antibody introduction, etc. Tachykinin Receptor 1 Antibody Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Tachykinin Receptor 1 Antibody market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Tachykinin Receptor 1 Antibody
1.1 Tachykinin Receptor 1 Antibody Market Overview
1.1.1 Tachykinin Receptor 1 Antibody Product Scope
1.1.2 Tachykinin Receptor 1 Antibody Market Status and Outlook
1.2 Global Tachykinin Receptor 1 Antibody Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Tachykinin Receptor 1 Antibody Market Size by Region (2018-2029)
1.4 Global Tachykinin Receptor 1 Antibody Historic Market Size by Region (2018-2024)
1.5 Global Tachykinin Receptor 1 Antibody Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Tachykinin Receptor 1 Antibody Market Size (2018-2029)
1.6.1 North America Tachykinin Receptor 1 Antibody Market Size (2018-2029)
1.6.2 Europe Tachykinin Receptor 1 Antibody Market Size (2018-2029)
1.6.3 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size (2018-2029)
1.6.4 Latin America Tachykinin Receptor 1 Antibody Market Size (2018-2029)
1.6.5 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size (2018-2029)
2 Tachykinin Receptor 1 Antibody Market by Type
2.1 Introduction
2.1.1 Polyclonal
2.1.2 Monoclonal
2.2 Global Tachykinin Receptor 1 Antibody Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Tachykinin Receptor 1 Antibody Historic Market Size by Type (2018-2024)
2.2.2 Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Tachykinin Receptor 1 Antibody Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Tachykinin Receptor 1 Antibody Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Tachykinin Receptor 1 Antibody Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Tachykinin Receptor 1 Antibody Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Tachykinin Receptor 1 Antibody Revenue Breakdown by Type (2018-2029)
3 Tachykinin Receptor 1 Antibody Market Overview by Application
3.1 Introduction
3.1.1 Flow Cytometry
3.1.2 Immunocytochemistry
3.1.3 Immunofluorescence
3.1.4 Western Blot
3.1.5 Others
3.2 Global Tachykinin Receptor 1 Antibody Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Tachykinin Receptor 1 Antibody Historic Market Size by Application (2018-2024)
3.2.2 Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Tachykinin Receptor 1 Antibody Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Tachykinin Receptor 1 Antibody Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Tachykinin Receptor 1 Antibody Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Tachykinin Receptor 1 Antibody Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Tachykinin Receptor 1 Antibody Revenue Breakdown by Application (2018-2029)
4 Tachykinin Receptor 1 Antibody Competition Analysis by Players
4.1 Global Tachykinin Receptor 1 Antibody Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tachykinin Receptor 1 Antibody as of 2022)
4.3 Date of Key Players Enter into Tachykinin Receptor 1 Antibody Market
4.4 Global Top Players Tachykinin Receptor 1 Antibody Headquarters and Area Served
4.5 Key Players Tachykinin Receptor 1 Antibody Product Solution and Service
4.6 Competitive Status
4.6.1 Tachykinin Receptor 1 Antibody Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 LSBio
5.1.1 LSBio Profile
5.1.2 LSBio Main Business
5.1.3 LSBio Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.1.4 LSBio Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.1.5 LSBio Recent Developments
5.2 Advanced Targeting Solutions
5.2.1 Advanced Targeting Solutions Profile
5.2.2 Advanced Targeting Solutions Main Business
5.2.3 Advanced Targeting Solutions Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.2.4 Advanced Targeting Solutions Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.2.5 Advanced Targeting Solutions Recent Developments
5.3 United States Biological
5.3.1 United States Biological Profile
5.3.2 United States Biological Main Business
5.3.3 United States Biological Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.3.4 United States Biological Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.3.5 Everest Biotech Recent Developments
5.4 Everest Biotech
5.4.1 Everest Biotech Profile
5.4.2 Everest Biotech Main Business
5.4.3 Everest Biotech Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.4.4 Everest Biotech Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.4.5 Everest Biotech Recent Developments
5.5 NSJ Bioreagents
5.5.1 NSJ Bioreagents Profile
5.5.2 NSJ Bioreagents Main Business
5.5.3 NSJ Bioreagents Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.5.4 NSJ Bioreagents Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.5.5 NSJ Bioreagents Recent Developments
5.6 ProSci
5.6.1 ProSci Profile
5.6.2 ProSci Main Business
5.6.3 ProSci Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.6.4 ProSci Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.6.5 ProSci Recent Developments
5.7 Cusabio
5.7.1 Cusabio Profile
5.7.2 Cusabio Main Business
5.7.3 Cusabio Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.7.4 Cusabio Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.7.5 Cusabio Recent Developments
5.8 FineTest
5.8.1 FineTest Profile
5.8.2 FineTest Main Business
5.8.3 FineTest Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.8.4 FineTest Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.8.5 FineTest Recent Developments
5.9 GeneTex
5.9.1 GeneTex Profile
5.9.2 GeneTex Main Business
5.9.3 GeneTex Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.9.4 GeneTex Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.9.5 GeneTex Recent Developments
5.10 Santa Cruz Biotechnology
5.10.1 Santa Cruz Biotechnology Profile
5.10.2 Santa Cruz Biotechnology Main Business
5.10.3 Santa Cruz Biotechnology Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.10.4 Santa Cruz Biotechnology Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.10.5 Santa Cruz Biotechnology Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.11.4 Merck Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.11.5 Merck Recent Developments
5.12 Atlas Antibodies
5.12.1 Atlas Antibodies Profile
5.12.2 Atlas Antibodies Main Business
5.12.3 Atlas Antibodies Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.12.4 Atlas Antibodies Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.12.5 Atlas Antibodies Recent Developments
5.13 Proteintech
5.13.1 Proteintech Profile
5.13.2 Proteintech Main Business
5.13.3 Proteintech Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.13.4 Proteintech Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.13.5 Proteintech Recent Developments
5.14 Boster Biological Technology
5.14.1 Boster Biological Technology Profile
5.14.2 Boster Biological Technology Main Business
5.14.3 Boster Biological Technology Tachykinin Receptor 1 Antibody Products, Services and Solutions
5.14.4 Boster Biological Technology Tachykinin Receptor 1 Antibody Revenue (US$ Million) & (2018-2024)
5.14.5 Boster Biological Technology Recent Developments
6 North America
6.1 North America Tachykinin Receptor 1 Antibody Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Tachykinin Receptor 1 Antibody Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tachykinin Receptor 1 Antibody Market Dynamics
11.1 Tachykinin Receptor 1 Antibody Industry Trends
11.2 Tachykinin Receptor 1 Antibody Market Drivers
11.3 Tachykinin Receptor 1 Antibody Market Challenges
11.4 Tachykinin Receptor 1 Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Tachykinin Receptor 1 Antibody Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Tachykinin Receptor 1 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Tachykinin Receptor 1 Antibody Market Size Share by Region (2018-2024)
Table 4. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Tachykinin Receptor 1 Antibody Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Tachykinin Receptor 1 Antibody Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Tachykinin Receptor 1 Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2018-2024)
Table 9. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2024-2029)
Table 11. North America Tachykinin Receptor 1 Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Tachykinin Receptor 1 Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Tachykinin Receptor 1 Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Tachykinin Receptor 1 Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Tachykinin Receptor 1 Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Tachykinin Receptor 1 Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Tachykinin Receptor 1 Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Tachykinin Receptor 1 Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Tachykinin Receptor 1 Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Tachykinin Receptor 1 Antibody Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Tachykinin Receptor 1 Antibody Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Tachykinin Receptor 1 Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2018-2024)
Table 24. Global Tachykinin Receptor 1 Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2024-2029)
Table 26. North America Tachykinin Receptor 1 Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Tachykinin Receptor 1 Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Tachykinin Receptor 1 Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Tachykinin Receptor 1 Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Tachykinin Receptor 1 Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Tachykinin Receptor 1 Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Tachykinin Receptor 1 Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Tachykinin Receptor 1 Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Tachykinin Receptor 1 Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Tachykinin Receptor 1 Antibody Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Tachykinin Receptor 1 Antibody Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Tachykinin Receptor 1 Antibody Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tachykinin Receptor 1 Antibody as of 2022)
Table 39. Date of Key Players Enter into Tachykinin Receptor 1 Antibody Market
Table 40. Global Tachykinin Receptor 1 Antibody Key Players Headquarters and Area Served
Table 41. Tachykinin Receptor 1 Antibody Product Solution and Service
Table 42. Global Tachykinin Receptor 1 Antibody Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. LSBio Basic Information List
Table 45. LSBio Description and Business Overview
Table 46. LSBio Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 47. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of LSBio (2018-2024)
Table 48. LSBio Recent Developments
Table 49. Advanced Targeting Solutions Basic Information List
Table 50. Advanced Targeting Solutions Description and Business Overview
Table 51. Advanced Targeting Solutions Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 52. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Advanced Targeting Solutions (2018-2024)
Table 53. Advanced Targeting Solutions Recent Developments
Table 54. United States Biological Basic Information List
Table 55. United States Biological Description and Business Overview
Table 56. United States Biological Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 57. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of United States Biological (2018-2024)
Table 58. United States Biological Recent Developments
Table 59. Everest Biotech Basic Information List
Table 60. Everest Biotech Description and Business Overview
Table 61. Everest Biotech Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 62. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Everest Biotech (2018-2024)
Table 63. Everest Biotech Recent Developments
Table 64. NSJ Bioreagents Basic Information List
Table 65. NSJ Bioreagents Description and Business Overview
Table 66. NSJ Bioreagents Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 67. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of NSJ Bioreagents (2018-2024)
Table 68. NSJ Bioreagents Recent Developments
Table 69. ProSci Basic Information List
Table 70. ProSci Description and Business Overview
Table 71. ProSci Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 72. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of ProSci (2018-2024)
Table 73. ProSci Recent Developments
Table 74. Cusabio Basic Information List
Table 75. Cusabio Description and Business Overview
Table 76. Cusabio Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 77. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Cusabio (2018-2024)
Table 78. Cusabio Recent Developments
Table 79. FineTest Basic Information List
Table 80. FineTest Description and Business Overview
Table 81. FineTest Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 82. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of FineTest (2018-2024)
Table 83. FineTest Recent Developments
Table 84. GeneTex Basic Information List
Table 85. GeneTex Description and Business Overview
Table 86. GeneTex Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 87. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of GeneTex (2018-2024)
Table 88. GeneTex Recent Developments
Table 89. Santa Cruz Biotechnology Basic Information List
Table 90. Santa Cruz Biotechnology Description and Business Overview
Table 91. Santa Cruz Biotechnology Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 92. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Santa Cruz Biotechnology (2018-2024)
Table 93. Santa Cruz Biotechnology Recent Developments
Table 94. Merck Basic Information List
Table 95. Merck Description and Business Overview
Table 96. Merck Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 97. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Merck (2018-2024)
Table 98. Merck Recent Developments
Table 99. Atlas Antibodies Basic Information List
Table 100. Atlas Antibodies Description and Business Overview
Table 101. Atlas Antibodies Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 102. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Atlas Antibodies (2018-2024)
Table 103. Atlas Antibodies Recent Developments
Table 104. Proteintech Basic Information List
Table 105. Proteintech Description and Business Overview
Table 106. Proteintech Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 107. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Proteintech (2018-2024)
Table 108. Proteintech Recent Developments
Table 109. Boster Biological Technology Basic Information List
Table 110. Boster Biological Technology Description and Business Overview
Table 111. Boster Biological Technology Tachykinin Receptor 1 Antibody Products, Services and Solutions
Table 112. Revenue (US$ Million) in Tachykinin Receptor 1 Antibody Business of Boster Biological Technology (2018-2024)
Table 113. Boster Biological Technology Recent Developments
Table 114. North America Tachykinin Receptor 1 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 115. North America Tachykinin Receptor 1 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 116. Europe Tachykinin Receptor 1 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 117. Europe Tachykinin Receptor 1 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 118. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 120. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 121. Asia-Pacific Tachykinin Receptor 1 Antibody Market Share by Region (2018-2024)
Table 122. Asia-Pacific Tachykinin Receptor 1 Antibody Market Share by Region (2024-2029)
Table 123. Latin America Tachykinin Receptor 1 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 124. Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 125. Latin America Tachykinin Receptor 1 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 126. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 127. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 128. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 129. Tachykinin Receptor 1 Antibody Market Trends
Table 130. Tachykinin Receptor 1 Antibody Market Drivers
Table 131. Tachykinin Receptor 1 Antibody Market Challenges
Table 132. Tachykinin Receptor 1 Antibody Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tachykinin Receptor 1 Antibody Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Tachykinin Receptor 1 Antibody Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Tachykinin Receptor 1 Antibody Market Share by Regions: 2022 VS 2029
Figure 4. Global Tachykinin Receptor 1 Antibody Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Tachykinin Receptor 1 Antibody Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Tachykinin Receptor 1 Antibody Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Tachykinin Receptor 1 Antibody Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Tachykinin Receptor 1 Antibody Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Tachykinin Receptor 1 Antibody Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Polyclonal
Figure 11. Global Polyclonal Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Monoclonal
Figure 13. Global Monoclonal Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Tachykinin Receptor 1 Antibody Market Size Share by Type: 2022 & 2029
Figure 15. North America Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2018-2029)
Figure 16. Europe Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Tachykinin Receptor 1 Antibody Revenue Market Share by Type (2018-2029)
Figure 20. Flow Cytometry Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Immunocytochemistry Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Immunofluorescence Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Western Blot Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Global Tachykinin Receptor 1 Antibody Market Size Share by Application: 2022 & 2029
Figure 26. North America Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2018-2029)
Figure 27. Europe Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2018-2029)
Figure 28. Asia-Pacific Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2018-2029)
Figure 29. Latin America Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2018-2029)
Figure 30. Middle East and Africa Tachykinin Receptor 1 Antibody Revenue Market Share by Application (2018-2029)
Figure 31. Tachykinin Receptor 1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Tachykinin Receptor 1 Antibody Market Share in 2022
Figure 33. North America Tachykinin Receptor 1 Antibody Market Share by Country (2018-2029)
Figure 34. United States Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 35. Canada Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 36. Germany Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 37. France Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 38. U.K. Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 39. Italy Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 40. Russia Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 41. Nordic Countries Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 42. Asia-Pacific Tachykinin Receptor 1 Antibody Market Share by Region (2018-2029)
Figure 43. China Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 44. Japan Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 45. South Korea Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 47. India Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 48. Australia Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 49. Latin America Tachykinin Receptor 1 Antibody Market Share by Country (2018-2029)
Figure 50. Mexico Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 51. Brazil Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Tachykinin Receptor 1 Antibody Market Share by Country (2018-2029)
Figure 53. Turkey Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 55. UAE Tachykinin Receptor 1 Antibody Market Size (2018-2029) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report